2021-01-07,Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-17,Aligos Therapeutics Presents Update on Development of SARS-CoV-2 Therapeutic Candidate and Screening Method in Collaboration with KU Leuven at RespiDART & Emerging Viruses 2020
2020-12-07,Aligos Enters into an Exclusive License and Research Collaboration Agreement with Merck to Discover and Develop an Oligonucleotide Therapy for NASH
2020-11-18,Time to Make a Move? J.P. Morgan Offers 3 Stocks to Buy
2020-11-16,"Aligos Therapeutics Presents Data on Chronic Hepatitis B, NASH and Hepatocellular Carcinoma Programs at AASLDs The Liver Meeting Digital Experience 2020"
2020-11-13,Aligos Therapeutics Announces Presentations at the Jefferies Virtual London Healthcare Conference & the Piper Sandler Annual Healthcare Conference
2020-11-12,Aligos Therapeutics is awarded 1.8M VLAIO grant to advance chronic hepatitis B research
2020-10-30,Aligos Therapeutics Doses First Subject in Phase 1 Proof-of-Concept Study of Small Molecule Drug Candidate ALG-000184 for Chronic Hepatitis B
2020-10-23,"Foghorn Therapeutics, the Latest Biotech to Go Public, Rises 13% in Its Market Debut"
2020-10-16,Hearing-Aid Maker Eargo Soars 87% in Its First Trading Day
2020-10-16,Theres an IPO Party in Biotech. Praxis Precision Led Fridays Slate With a 62% Pop.
2020-10-16,"Aligos Therapeutics stock rallies out of the gate, then pulls back"
2020-10-15,Aligos Therapeutics Announces Pricing of Initial Public Offering
